{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:53:36Z","timestamp":1771037616272,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.amjmed.2005.05.009","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T10:48:06Z","timestamp":1120301286000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"S","title":["Appropriate antibiotic treatment of genitourinary infections in hospitalized patients"],"prefix":"10.1016","volume":"118","author":[{"given":"Hans","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Grant","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.05.009_bib1","unstructured":"McCue JD. The management of complicated urinary tract infections. Infectious Diseases InfoAlert. Daiichi Pharmaceutical Asia Ltd. Web site. Available at: http:\/\/www.dpa.com.hk\/info.htm. Accessed October 6, 2004."},{"key":"10.1016\/j.amjmed.2005.05.009_bib2","first-page":"15","article-title":"Hospital-acquired urinary tract infections","volume":"4","author":"Iannini","year":"2002","journal-title":"Current Treatment Options in Infectious Diseases"},{"key":"10.1016\/j.amjmed.2005.05.009_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","article-title":"Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System","volume":"27","author":"Richards","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.amjmed.2005.05.009_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid0702.010240","article-title":"Engineering out the risk for infection with urinary catheters","volume":"7","author":"Maki","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib6","first-page":"153","article-title":"Epidemiology of urinary tract infection","volume":"18","author":"Nicolle","year":"2001","journal-title":"Infect Med"},{"key":"10.1016\/j.amjmed.2005.05.009_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0891-5520(05)70373-1","article-title":"Diagnosis and treatment of uncomplicated urinary tract infection","volume":"11","author":"Hooton","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.amjmed.2005.05.009_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/46.suppl_1.1","article-title":"Pathogenesis of urinary tract infections","volume":"46","author":"Hooton","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2005.05.009_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0733-8627(05)70210-8","article-title":"Prostatitis","volume":"19","author":"Lummus","year":"2001","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.amjmed.2005.05.009_bib10","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJM199310283291808","article-title":"Management of urinary tract infections in adults","volume":"329","author":"Stamm","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.05.009_bib11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2165\/00003495-200464120-00007","article-title":"Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections","volume":"64","author":"Carson","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.amjmed.2005.05.009_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/423000","article-title":"A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury","volume":"39","author":"Dow","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2005.05.009_bib13","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/318844","article-title":"Urinary tract pathogens in complicated infection and in elderly individuals","volume":"183","author":"Nicolle","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1742-1241.2003.tb10513.x","article-title":"Hospital-acquired urinary tract infection","volume":"57","author":"Kalsi","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.amjmed.2005.05.009_bib15","unstructured":"Nicolle LE. Use of ofloxacin in the treatment of chronic and compli-cated urinary tract infection in the elderly. Infectious Diseases InfoAlert. Daiichi Pharmaceutical Asia Ltd. Web site. Available at: http:\/\/www.dpa.com.hk\/info.htm. Accessed October 6, 2004"},{"key":"10.1016\/j.amjmed.2005.05.009_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0090-4295(02)02300-2","article-title":"Antimicrobial therapy for bacterial and nonbacterial prostatitis","volume":"60","author":"Fowler","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2005.05.009_bib17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.35.9.1849","article-title":"Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection","volume":"35","author":"Fang","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2005.05.009_bib18","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1086\/426189","article-title":"Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections","volume":"40","author":"Burgess","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib19","first-page":"45","article-title":"Urinary tract infections","volume":"57","author":"O\u2019Donnell","year":"2002","journal-title":"Geriatrics"},{"key":"10.1016\/j.amjmed.2005.05.009_bib20","series-title":"Proceedings of the TRUST 7 (2002\u20132003) Surveillance Study","article-title":"Data on file","year":"2003"},{"key":"10.1016\/j.amjmed.2005.05.009_bib21","series-title":"Proceedings of the TRUST 8 (2004) Investigators\u2019 Meeting; May 25, 2004; New Orleans, LA","article-title":"Data on file","year":"2004"},{"key":"10.1016\/j.amjmed.2005.05.009_bib22","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/archinte.164.15.1662","article-title":"Clinicians\u2019 perceptions of the problem of antimicrobial resistance in health care facilities","volume":"164","author":"Giblin","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2005.05.009_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib24","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.05.009_bib25","unstructured":"Talan DA. Treatment of complicated urinary tract infections\u2014emerging role of extended-release ciprofloxacin. Touch Briefings Web site. Available at: http:\/\/www.bbriefings.com. Accessed October 6, 2004."},{"key":"10.1016\/j.amjmed.2005.05.009_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s100960050488","article-title":"Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women","volume":"19","author":"Raz","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib27","first-page":"49","article-title":"Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections [in Italian]","volume":"75","author":"Trinchieri","year":"2003","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.amjmed.2005.05.009_bib28","first-page":"33","article-title":"Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections","volume":"32","author":"Peng","year":"1999","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.amjmed.2005.05.009_bib29","series-title":"Infect Diseases","first-page":"788","article-title":"Urinary tract infections. Approach to the patient with urinary tract infections","author":"Stamm","year":"1992"},{"key":"10.1016\/j.amjmed.2005.05.009_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-4295(03)00565-X","article-title":"Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis","volume":"62","author":"Bundrick","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2005.05.009_bib31","unstructured":"Trovan\u00ae (trovafloxacin) New Drug Application. US Food and Drug Administration Web site. Available at: http:\/\/www.fda.gov\/cder\/foi\/nda\/97\/020760a_medr_P6.pdf. Accessed October 13, 2004"},{"key":"10.1016\/j.amjmed.2005.05.009_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1185\/030079904125003223","article-title":"Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital","volume":"20","author":"Rapp","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 3","key":"10.1016\/j.amjmed.2005.05.009_bib33","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1098-3597(03)90027-5","article-title":"Safety and tolerability of fluoroquinolones","author":"Sprandel","year":"2003","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.amjmed.2005.05.009_bib34","series-title":"Tequin [package insert]","year":"2004"},{"key":"10.1016\/j.amjmed.2005.05.009_bib35","series-title":"Levaquin [package insert]","year":"2004"},{"key":"10.1016\/j.amjmed.2005.05.009_bib36","series-title":"Avelox [package insert]","year":"2004"},{"key":"10.1016\/j.amjmed.2005.05.009_bib37","series-title":"Factive [package insert]","year":"2004"},{"key":"10.1016\/j.amjmed.2005.05.009_bib38","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","article-title":"Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients","volume":"343","author":"Donskey","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.05.009_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/AAC.45.2.589-592.2001","article-title":"Comparative antianaerobic activity of BMS 284756","volume":"45","author":"Hoellman","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2005.05.009_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0195-6701(03)00115-4","article-title":"Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital","volume":"54","author":"Khan","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.amjmed.2005.05.009_bib41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/381551","article-title":"Outbreak of clostridium difficile infection in a long-term care facility","volume":"38","author":"Gaynes","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/338260","article-title":"Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile","volume":"34","author":"Kyne","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.05.009_bib43","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","article-title":"Timing of new black box warnings and withdrawals for prescription medications","volume":"287","author":"Lasser","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.05.009_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"A critical review of the fluoroquinolones","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.amjmed.2005.05.009_bib45","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.44.8.2046-2051.2000","article-title":"A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin","volume":"44","author":"Drusano","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305003839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305003839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:38:13Z","timestamp":1757579893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305003839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0002934305003839"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.05.009","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate antibiotic treatment of genitourinary infections in hospitalized patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}